scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023730781 |
P356 | DOI | 10.1186/CC10072 |
P932 | PMC publication ID | 3219332 |
P698 | PubMed publication ID | 21366903 |
P5875 | ResearchGate publication ID | 50265911 |
P50 | author | Kyong Ran Peck | Q38641275 |
Kyung Mok Sohn | Q42408453 | ||
Mi Kyong Joung | Q56926819 | ||
Gee Young Suh | Q86988444 | ||
Soo-Youn Moon | Q87057921 | ||
Doo Ryeon Chung | Q88159934 | ||
Eun Jeong Joo | Q88300621 | ||
Hae Suk Cheong | Q90299494 | ||
Seung Min Chung | Q91125991 | ||
P2093 | author name string | Jae-Hoon Song | |
Young-Eun Ha | |||
Jeong-a Lee | |||
P2860 | cites work | Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 |
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
APACHE II: a severity of disease classification system | Q29547729 | ||
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription | Q33912931 | ||
Present situation of antimicrobial resistance in Korea | Q34505590 | ||
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting | Q34509624 | ||
High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. | Q34576870 | ||
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study | Q34999543 | ||
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. | Q35022253 | ||
Clinical approach to the patient with suspected ventilator-associated pneumonia. | Q36171407 | ||
Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia | Q36856249 | ||
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients | Q39487652 | ||
CDC definitions for nosocomial infections, 1988 | Q39605670 | ||
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia | Q39608037 | ||
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia | Q39661220 | ||
A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia | Q39684575 | ||
Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results | Q39733706 | ||
Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. | Q46001422 | ||
De-escalation therapy in ventilator-associated pneumonia | Q47868453 | ||
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. | Q51206353 | ||
Nosocomial pneumonia. A multivariate analysis of risk and prognosis. | Q52573110 | ||
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia | Q57238120 | ||
Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients | Q68535966 | ||
Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group | Q71510515 | ||
Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited | Q73372258 | ||
P433 | issue | 2 | |
P921 | main subject | pneumonia | Q12192 |
intensive care unit | Q5094647 | ||
P304 | page(s) | R79 | |
P577 | publication date | 2011-03-02 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia | |
P478 | volume | 15 |
Q38679343 | A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit |
Q38712768 | A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia. |
Q36666990 | A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia |
Q37563029 | An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy |
Q55018607 | Antibiotics De-Escalation in the Treatment of Ventilator-Associated Pneumonia in Trauma Patients: A Retrospective Study on Propensity Score Matching Method. |
Q43240867 | Antimicrobial de-escalation in septic cancer patients: is it safe to back down? |
Q36455347 | Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration |
Q38198157 | Antimicrobial stewardship of β-lactams in intensive care units |
Q36774787 | Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections |
Q92356332 | Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition) |
Q90329443 | Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort |
Q44692768 | De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. |
Q37132283 | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study. |
Q36089167 | Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance |
Q33749860 | Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients |
Q40370311 | Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa |
Q49061695 | Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study |
Q42264706 | Infection control team activity and recent antibiograms in the Kobe University Hospital |
Q36078359 | Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society |
Q83390539 | Management of antimicrobial use in the intensive care unit |
Q64977019 | Réévaluation clinico-biologique de l’antibiothérapie probabiliste en réanimation des brules. |
Q91992768 | Safety of antimicrobial de-escalation for culture-negative severe pneumonia |
Q27002517 | Strategies for appropriate antibiotic use in intensive care unit |
Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
Q38307688 | The bacterial pneumonias: a new treatment paradigm |
Q50141533 | The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record |
Q38271775 | Ventilator-associated pneumonia: present understanding and ongoing debates |
Q48185895 | When antibiotic treatment fails |